Back to Agenda
Insights Regarding Implementation of the ASAP Process
Session Chair(s)
Greg Ball, PHD
Safety Data Scientist
ASAPprocess, United States
We will focus on insights regarding implementation of the ASAP process, how it has been beneficial to implement, and results from a survey across a targeted sample of forward-thinking pharma companies (big and small).
Learning Objective : Describe the steps to implement the ASAP process at a smaller company with limited resources; Identify specific effficiencies achieved when applying the ASAP process to platform products or product families with shared componentts; Recognize how the ASAP process has been beneficial to implement for various projects.
Speaker(s)
Advantages of Earlier Systematic and Strategic Safety Planning
Famina Hemani, PHARMD
Tourmaline Bio, United States
Vice President, Head of Pharmacovigilance
Insights Regarding Implementation of the ASAP Process
Barbara Hendrickson, DrMed, MD
University of Chicago, United States
Clinical Associate, Pediatric Infectious Diseases
Practical Implementation of ASAP Concepts
Cynthia McShea, MPH
UCB Biosciences, United States
Head, Safety Statistics
Have an account?